CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- 8-K Event Results of operations
- 8-K Event Material agreement · Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 20,000 shares at an average $7.31 ($146,290)
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Open-market buy 10% owner bought 74,584 shares at an average $8.34 ($622,389)
- 8-K Event Material agreement · New debt or obligation · Other events
- 424B5 Offering Prospectus
- FWP Offering Free Writing Prospectus
- 8-K Event Regulation FD disclosure
- 424B5 Offering Prospectus
- 8-K Event Executive or director change · Shareholder vote results
Page 14 of 44 · 872 filings